Alessandra Murgia

Dr. Alessandra Murgia

Neurodevelopmental Molecular Genetics Laboratory, Department of Women’s and Children’s Health SDB, Università degli Studi di Padova, Padua, Italy
orcid

Research Focus & Metrics

Academic Career Length

29Years (1998-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 July 2014 in Journal of Neurodevelopmental Disorders
Verified
Journal Article
Open access
PDF file
CYCarolyn Yrigollen
Carolyn Yrigollen
LMLoreto Martorell
Loreto Martorell
BDBlythe Durbin-Johnson
Blythe Durbin-Johnson
MNMontserrat Naudo
Montserrat Naudo
JGJordi Genoves
Jordi Genoves
FTFlora Tassone
Flora Tassone
The presence of AGG interruptions in the CGG repeat locus of the fragile X mental retardation 1 (FMR1) gene decreases the instability of the allele during transmission from parent to child, and decreases the risk of expansion of a premutation allele to a full mutation allele (the predominant cause of fragile X syndrome) during maternal transmission.

1 January 2010 in Brain and Development
Verified
Journal Article
Closed access
RARosangela Artuso
Rosangela Artuso
MMM.A. Mencarelli
M.A. Mencarelli
RPRoberta Polli
Roberta Polli
SSStefano Sartori
Stefano Sartori
Francesca ArianiFrancesca Ariani
Francesca Ariani
AMAlessandra Murgia
Alessandra Murgia

15 October 2019 in Nature Communications
Verified
Journal Article
Open access
PDF file
HGHui Guo
Hui Guo
EBElisa Bettella
Elisa Bettella
PMPaul C. Marcogliese
Paul C. Marcogliese
RZRongjuan Zhao
Rongjuan Zhao
JAJonathan C. Andrews
Jonathan C. Andrews
FMF. Kumara Eugene Mastrorosa
F. Kumara Eugene Mastrorosa
Postsynaptic density (PSD) proteins have been implicated in the pathophysiology of neurodevelopmental and psychiatric disorders. Here, we present detailed clinical and genetic data for 20 patients with likely gene-disrupting mutations in TANC2—whose protein product interacts with multiple PSD proteins. Pediatric patients with disruptive mutations present with autism, intellectual disability, and delayed language and motor development. In addition to a variable degree of epilepsy and facial dysmorphism, we observe a pattern of more complex psychiatric dysfunction or behavioral problems in adult probands or carrier parents. Although this observation requires replication to establish statistical significance, it also suggests that mutations in this gene are associated with a variety of neuropsychiatric disorders consistent with its postsynaptic function. We find that TANC2 is expressed broadly in the human developing brain, especially in excitatory neurons and glial cells, but shows a more restricted pattern in Drosophila glial cells where its disruption affects behavioral outcomes.

15 May 2023 in Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
CGCharlotte Gehin
Charlotte Gehin
MLMuseer Lone
Museer Lone
WLWinston Lee
Winston Lee
LCLaura Capolupo
Laura Capolupo
SHSylvia Ho
Sylvia Ho
VGVincenzo A. Gennarino
Vincenzo A. Gennarino
Neural differentiation, synaptic transmission, and action potential propagation depend on membrane sphingolipids, whose metabolism is tightly regulated. Mutations in the ceramide transporter CERT (CERT1), which is involved in sphingolipid biosynthesis, are associated with intellectual disability, but the pathogenic mechanism remains obscure. Here, we characterize 31 individuals with de novo missense variants in CERT1. Several variants fall into a previously uncharacterized dimeric helical domain that enables CERT homeostatic inactivation, without which sphingolipid production goes unchecked. The clinical severity reflects the degree to which CERT autoregulation is disrupted, and inhibiting CERT pharmacologically corrects morphological and motor abnormalities in a Drosophila model of the disease, which we call ceramide transporter (CerTra) syndrome. These findings uncover a central role for CERT autoregulation in the control of sphingolipid biosynthetic flux, provide unexpected insight into the structural organization of CERT, and suggest a possible therapeutic approach for patients with CerTra syndrome.

3 July 2018 in European Journal of Paediatric Neurology
Verified
Journal Article
Closed access
PDF file
ITIrene Toldo
Irene Toldo
CBClaudia Maria Bonardi
Claudia Maria Bonardi
EBElisa Bettella
Elisa Bettella
RPRoberta Polli
Roberta Polli
GTGiacomo Talenti
Giacomo Talenti
AMAlessandra Murgia
Alessandra Murgia

22 January 2009 in American Journal of Medical Genetics Part A
Verified
Journal Article
Closed access
PDF file
SSStefano Sartori
Stefano Sartori
GRGabriella Di Rosa
Gabriella Di Rosa
RPRoberta Polli
Roberta Polli
EBElisa Bettella
Elisa Bettella
GTGiovanni Tricomi
Giovanni Tricomi
AMAlessandra Murgia
Alessandra Murgia